Brave new (strept)avidins in biotechnology

Avidin and streptavidin are widely used in (strept)avidin–biotin technology, which is based on their tight biotin-binding capability. These techniques are exceptionally diverse, ranging from simple purification and labeling methods to sophisticated drug pre-targeting and nanostructure-building appro...

Full description

Saved in:
Bibliographic Details
Published in:Trends in biotechnology (Regular ed.) Vol. 25; no. 6; pp. 269 - 277
Main Authors: Laitinen, Olli H, Nordlund, Henri R, Hytönen, Vesa P, Kulomaa, Markku S
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 01-06-2007
Elsevier Science
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Avidin and streptavidin are widely used in (strept)avidin–biotin technology, which is based on their tight biotin-binding capability. These techniques are exceptionally diverse, ranging from simple purification and labeling methods to sophisticated drug pre-targeting and nanostructure-building approaches. Improvements in protein engineering have provided new possibilities to develop tailored protein tools. The (strept)avidin scaffold has been engineered to extend the existing range of applications and to develop new ones. Modifications to (strept)avidins – such as simple amino acid substitutions to reduce biotin binding and alter physico–chemical characters – have recently developed into more sophisticated changes, including chimeric (strept)avidins, topology rearrangements and stitching of non-natural amino acids into the active sites. In this review, we highlight the current status in genetically engineered (strept)avidins and illustrate their versatility as advanced tools in the multiple fields of modern bioscience, medicine and nanotechnology.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0167-7799
1879-3096
DOI:10.1016/j.tibtech.2007.04.001